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1. Introduction 
Erythrocytes are produced by a complex and finely regulated process of erythropoiesis. It 
starts with a pluripotential stem cell that, in addition of its self replication capacity, can give 
rise to separate cell lineages. Erythropoiesis passes from the stem cell through the 
multipotent progenitor CFU-GEMM (colony-forming unit granulocyte erythroid monocyte 
and megakaryocyte), and then BFU-E (burst-forming unit erythroid) and CFU-E (colony-
forming unit eryhtroid), to the first recognizable erythrocyte precursor in the bone marrow, 
the pronormoblast. This cell gives rise to a series of progressively smaller normoblasts with 
increasing content of hemoglobin. The nucleus is finally extruded from the late normoblast 
leading to mature red blood cell through the reticulocyte stage. Erythropoiesis ends with the 
mature circulating red cell, which is a non-nucleated biconcave disc, performing its function 
of oxygen delivery. In this process, the glycoprotein hormone erythropoietin has been 
known as the major humoral regulator of red cell production. It is now well established that 
erythropoietin stimulates erythropoiesis, at least in part, by protecting erythroblasts from 
apoptosis. 
Human mature erythrocytes are terminally differentiated cells that are devoid of 
mitochondria, as well as of nucleus and other organelles. In circulation, the red cell is 
constantly tested for its capacity to undergo marked cellular deformation. This ability to 
change its shape is essential for optimal cell function, since the resting diameter of the 
human red cell far exceeds that of the capillaries and splenic endothelial slits through which 
it must pass (Mohandas & Groner, 1989). A two dimensional network of proteins interacting 
between transmembrane location and cytoplasmic surface of the plasma membrane gives 
the red blood cell its properties of elasticity and flexibility that allows the success of this 
journey.   
The mature erythrocyte is unable to self-repair and has no capacity to synthesize proteins. 
Therefore, its lifespan is finite and is shortened further when the cell’s environment becomes 
hostile or when the erythrocyte’s ability to cope with damaging extracellular influences 
becomes impaired. The erythrocyte limited lifespan implies that, as in other cells, life and 
death are well regulated for erythrocytes, in spite of their lack of capacity for protein 
synthesis (Bosman et al., 2005).  
In the present review, we aim to show updated information concerning erythrocyte death in 
order to contribute to the understanding of the physiopathological relationship of this 
process with the development of anemia. 
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2. Anemia 
The term anemia is derived from ancient Greek for "bloodlessness". It is a condition 
involving abnormal reduction of hemoglobin content. In healthy adults, there is steady-state 
equilibrium between the rate of release of new red cells from the bone marrow into the 
circulation and the rate of removal of senescent red cells from the circulation by 
reticuloendothelial system. Balance disruption appears by decreased cell production, 
increased destruction or both, leading then to anemia. Different mechanisms which may 
lead to anemia are blood loss, decreased red cell lifespan, acquired or congenital defects, 
ineffective erythropoiesis, and impairment of red cell formation.  
In this chapter we focus on anemia resulting from accelerated clearance of red blood cells 
from circulating blood before hemolysis.  
3. Erythrocyte death 
Apoptosis is a regulated process of self-destruction characterized by a series of changes 
affecting the nucleus, cytoplasm and plasma membrane of the cell, and leading to the rapid 
capture and ingestion of the dying cell by macrophages. Programmed death allows the 
elimination of cells without release of intracellular proteins which would otherwise cause 
inflammation. 
It is well known that eukaryotic cells use a similar death program. Moreover, erythrocyte 
precursors, which are true organelle-containing cells, are susceptible to apoptosis induction. 
Instead, human mature erythrocytes have been considered as unable to undergo 
programmed cell death due to their lack of mitochondria, nucleus, and other organelles. 
Increasing evidence is now available to demonstrate that mature erythrocytes can undergo a 
rapid self-destruction process sharing several features with apoptosis, including cell 
shrinkage, plasma membrane microvesiculation, shape changes, cytoskeleton alterations 
associated with protein degradation, and loss of plasma membrane phospholipid 
asymmetry leading to the externalization of phosphatidylserine. As described, erythrocyte 
death is characterized by some features that are shared by apoptosis. To distinguish the 
death of erythrocytes from apoptosis of nucleated cells, some authors suggest the term 
“eryptosis” (Lang KS et al., 2005). 
Erythrocyte lifespan is limited to approximately 120 days and is ended by a process of 
senescence during which aging erythrocytes suffer changes that display molecules that are 
recognized by macrophages leading to their clearance from peripheral blood by 
reticuloendothelial system (Bratosin et al., 1998). Programmed erythrocyte death prevents 
intravascular hemolysis and allows the elimination of cells without inflammation. Even 
though this is one of the processes that regulate effective erythropoiesis, a disturbance of the 
fine equilibrium between erythrocyte production and cell destruction may be caused by the 
presence of factors that create a harmful environment.  
The knowledge of the mechanism of the erythrocyte death is of the highest importance 
since, apart from its association with anemia, it could lead to improvements of the storage 
conditions in blood banks by increasing the time of viability of stored red blood cells 
(Bratosin et al., 2002). 
4. Mechanism of suicidal erythrocyte death 
As mentioned above, mature erythrocytes can undergo a rapid self-destruction process 
leading to increased intracellular calcium content, modifications of the erythrocyte 
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morphology, metabolic disruption, membrane protein modifications, and externalization of 
phosphatidylserine, thereby activating a clearance mechanism involving heterophagic 
removal in the reticuloendothelial system. 
Data describing cell changes and mechanism involved in erythrocyte premature death are 
stated below.  
4.1 Intracellular calcium content 
It is well established that two properties of red blood cells, deformability and elasticity, are 
dramatically affected by calcium ions. Thus, a rise in internal Ca2+ leads to changes in cell 
shape and volume, increased cellular rigidity and hemolysis (Weed et al., 1969; Palek et al., 
1974; Kirkpatrick et al., 1975). Such alterations seem to arise from Ca2+ interactions with 
various molecular targets. These include both low-affinity associations with membrane 
phospholipids (Chandra et al., 1987) and high-affinity ones with specific membrane proteins, 
especially the Ca-dependent K channel (Romero, 1976) as well as with some cytoskeletal 
proteins (Wallis et al., 1993). It was observed that the presence of the bivalent-cation ionophore 
A23187 did not induce erythrocyte death in the absence of extracellular Ca2+, nor in the 
presence of both Ca2+ and the Ca2+ chelator EDTA, thus characterizing erythrocyte death as an 
active process requiring Ca2+ entry into the cells (Bratosin et al., 2001). 
Since internal Ca2+ is subjected to metabolic control via an ATP-dependent extrusion 
mechanism (Ca pump) (Schatzmann, 1983), it is expected that the decreased ATP content 
attained during red cell aging should lead to raised cellular Ca2+. The homeostasis of Ca2+ in 
these cells is carried out by the concerted action of just two mechanisms: the active extrusion 
already mentioned and the entry through defined Ca2+ channels (Romero & Romero, 1999). 
Different factors that may cause cellular stress, such as hyperosmotic shock, oxidative stress, 
or energy depletion, are capable of Ca2+ channel activation in the erythrocyte, including the 
nonselective cation channel TRPC, with subsequent increased entry of Ca2+ (Föller el al., 
2008). It has been reported that free Ca2+ concentration, cell-shrinkage, and phospholipid 
scrambling were significantly lower in Cl--depleted TRPC6 -/- erythrocytes than in wildtype 
mouse erythrocytes, which let the authors conclude that human and mouse erythrocytes 
express TRPC6 cation channels which participate in cation leak and Ca2+-induced suicidal 
death (Föller el al., 2008).   
The increase in erythrocyte cytosolic Ca2+ concentration further stimulates Ca2+-sensitive K+ 
channel (Gardos channel). The subsequent efflux of K+ hyperpolarises the cell membrane, 
which drives Cl- exit in parallel to K+. The cellular loss of KCl with osmotically obliged 
water leads to cell shrinkage. It has been reported that cell shrinkage leads to formation of 
ceramide. This compound can also contribute to the triggering of cell membrane scrambling 
(Lang et al., 2004), one of the typical features of suicidal erythrocyte death. 
Another important effect caused by a raise in intracellular Ca2+ concerns the activation of 
different enzymes, including calpain. This endogenous protease primarily cleaves the Ca 
pump, then band 3 protein and finally some cytoskeletal proteins. 
4.2 Enzyme activity 
4.2.1 Enzymes of the glycolytic pathways  
Band 3, the anion-exchange protein, also binds various cytoskeletal proteins as well as 
hemoglobin and cytoplasmic glycolytic enzymes. It has been shown that mild oxidants, such 
as potassium ferricyanade, diamide, and hydrogen peroxide stimulate red blood cell 
glycolysis in proportion to the elevation of band 3 tyrosine phophorylation. Band 3 
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sequences surrounding tyrosine residues have been associated with intracellular binding of 
several cytosolic proteins, including hemoglobin and the glycolytic enzymes aldolase, 
phosphofructokinase, and glyceraldehyde-3-phosphate dehydrogenase. In vitro, the tyrosine 
phosphorylation of band 3 prevented the binding of these glycolytic enzymes. Since these 
enzymes are inhibited in their bound state, the functional consequence of N-terminal band 3 
tyrosine phosphorylation would be an enhanced rate of glycolysis in the intact cells 
(Harrison et al., 1991; Mallozi et al., 1995). This mechanism of erythrocyte metabolic 
regulation can stimulate or reduce energy production in times of special needs, such as 
during a free radical attack. 
4.2.2 Enzymes involved in thiol metabolism and protection against oxidative damage 
Activities of some cytoplasmic enzymes decline during erythrocyte aging or when they are 
induced to programmed cell death. Oxidative stress as well as antioxidant depletion cause 
decreased activity of erythrocyte catalase (CAT), superoxide dismutase (SOD), and glutathione 
peroxidase (GPX). However, the enzyme behavior seems to depend on the biological model as 
well as the oxidant agent, since there are some reports showing activation of CAT, SOD, and 
GPX which has been associated with the metabolic response to cell injure. 
4.2.3 Proteases 
Members of the caspase family contain a cystein residue in their active center and exist as 
zymogens that need to be activated by proteolytic cleavage adjacent to aspartates. During 
apoptosis, caspases function either as initiators (e.g. caspase-8 and -9) in response to 
proapoptotic signals or as effectors (e.g. caspase-3) (Berg et al., 2001). Mature erythrocytes 
contain considerable amounts of caspase-3 and caspase-8 whereas other essential 
components of the mitochondrial apoptotic cascade such as caspase-9, Apaf-1 and 
cytochrome c are absent. Strikingly, although caspase-3 and -8 were functionally active in 
vitro, they did not become activated by various proapoptotic stimuli. Cysteine protease 
inhibitors prevented programmed erythrocyte death induced by Ca2+ influx, and allowed 
erythrocyte survival in vitro and in vivo. However, the cysteine proteases involved seem not 
to be caspases, since caspase-3, while present in erythrocytes, was not activated during cell 
death, and cytochrome c, a critical component of the apoptosome, was lacking. Therefore, 
Ca2+-induced erythrocyte death appeared to proceed in the absence of caspase activation 
(Bratosin et al., 2001). In opposition, pretreatment of red cells with the caspase-8 or the 
caspase-3 specific inhibitors blocked the oxidative stress-induced inhibition of 
aminophospholipid translocase activity, leading to the conclusion that caspase-8 dependent 
caspase-3 activation could play a role in the phosphatidylserine externalization (Mandal et 
al., 2005). Other authors observed that treatment of erythrocytes with peroxynitrite under 
conditions in which the oxidant diffuses to the intracellular compartment led to 
phosphatidylserine translocation in parallel with activation of caspases (Pietraforte et al., 
2007). Taking together, the abovementioned results suggest that the role of caspases in the 
mature human erythrocytes needs to be clarified. 
The major Ca2+-activated cysteine protease found to be involved in the process of cell death 
is calpain. Following an increase of cytosolic calcium, calpain translocates from the cytosol 
to the membrane where it undergoes autoproteolytic activation. Although caspases were 
found inactive in senescent erythrocytes or cells treated with calcium ionophores, activation 
of the cysteine protease calpain was readily induced in response to elevated calcium levels 
(Berg et al., 2001). Red blood cells exposed to the oxidative agent peroxynitrite also showed 
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an increase of the active form of µ-calpain (Matarrese et al., 2005). In contrast, calpain 
inhibitors did not affect phosphatidylserine exposure suggesting that it is presumably a 
protease-independent event in erythrocytes. A possible explanation may be that increased 
intracellular calcium is sufficient to disrupt phospholipid asymmetry by activating an 
aminophospholipid scramblase and inactivating aminophospholipid translocase.  
The activation of calpain in normal human erythrocytes incubated in the presence of Ca2+ 
and ionophore A23187 led to the decline of the Ca2+-dependent ATPase activity of the cells, 
which was prevented by preloading of the erythrocyte with an anticalpain antibody. The 
decline of the pump activity corresponded to the degradation of the pump protein and was 
inversely correlated to the amount of the natural inhibitor of calpain, calpastatin, present in 
the cells. Results suggested that the Ca pump and band 3 were the most sensitive proteins to 
calpain-induced degradation (Salamino et al., 1994).  
Calpain was also responsible for phosphotyrosine phosphatase 1B (PTP1B) cleavage in 
platelets (Frangioni et al., 1993) and in cell lines with erythroid differentiation ability 
(Callero et al., 2011), which was accompanied by stimulation of its enzymatic activity. 
Reversible oxidation of PTP1B in vitro strongly facilitated the association with calpain and 
led to greatly increased calpain-dependent cleavage (Trümpler et al., 2009). Both oxidative 
environment and increased intracellular Ca2+ may account for the altered tyrosyl 
phosphorylation that may have important implications in the programmed erythrocyte 
death. 
4.3 Phosphatydilserine externalization  
Alterations in the transbilayer distribution of phospholipids in erythrocyte membrane have 
significant physiologic consequences. Phospholipids in the plasma membrane of 
mammalian cells are not randomly distributed between the two leaflets of the membrane 
bilayer. Choline-containing phospholipids phosphatidylcholine and sphingomyelin 
dominate the outer leaflet, while the aminophospholipids phosphatidylethanolamine and 
phosphatidylserine are major components of the inner leaflet (Williamson & Schlegel, 2002). 
Of these phospholipids, only phosphatidylserine demonstrates an absolute distribution, and 
the appearance of this lipid on the external surface has significant consequences for the red 
blood cell (Daleke, 2008). Several functional roles for asymmetric phospholipid distribution 
in plasma membranes have been suggested. For instance, several regulatory and structural 
proteins including protein kinase C (Palfrey & Waseem, 1985), annexin (Meers & Mealy, 
1994), and membrane skeletal proteins, such as spectrin (O’Toole et al., 1999), appear to 
localize to the cytoplasmic face of the membrane through their interaction with 
phosphatidylserine (Manno et al., 2002). 
Although asymmetric lipid synthesis and chemical modification make some contribution, 
ATP-dependent directional lipid transport is the primary mechanism for generation and 
maintenance of lipid asymmetry. The latter transport is catalyzed by an enzyme called the 
aminophospholipid translocase, a P-type ATPase that specifically and rapidly transports the 
aminophospholipids, phosphatidylethanolamine and phosphatidylserine, from the outer to 
the inner leaflet of the plasma membrane (Tang et al., 1996). At least one membrane protein 
is required to facilitate a rapid loss of lipid asymmetry. Although no protein mediating this 
function has been identified they are called “phospholipid scramblases”. The bivalent cation 
Ca2+ plays an important role in the regulation of lipid scrambling. In erythrocyte, once 
activated by Ca2+, the scrambling pathway remains active for at least 2 h (Williamson et al., 
1992). Scramblase creates a proteinaceous aqueous pore that facilitates migration of the 
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polar headgroup of the lipids across the hydrophobic core of the bilayer, while keeping the 
acyl chain moieties in the core of the bilayer (Bevers & Williamson, 2010). 
Whether triggered by injury, disease or cell activation, the movement of phosphatidylserine 
to the surface of the cell alters rheologic and hemostatic properties of the membrane. 
Erythrocytes with surface-exposed phosphatidylserine adhere to one another and to 
vascular endothelial cells (Daleke, 2008). Thus, the regulation and control of the distribution 
of phospholipid asymmetry are essential for maintenance erythrocyte mechanical stability 
and proper cell function. Furthermore, asymmetric distribution of aminophospholipids has 
significant effects on cell shape and on membrane mechanical stability. Ghosts that 
maintained their asymmetric lipid distribution had normal discoid morphology whereas 
ghosts in which asymmetric lipid distribution was lost exhibited echinocytic morphology 
(Manno et al., 2002). Understanding the cause of perturbations of transbilayer distribution of 
phospholipids and the molecular mechanism by which they are regulated is essential for 
ameliorating some of the consequences of erythrocyte membrane abnormalities. 
In summary, phosphatidylserine translocation, now generally accepted as a hallmark of cells 
in apoptosis, results from the inhibition of aminophospholipid translocase activity and 
activation of scramblase. Surface exposure of phosphatidylserine on apoptotic cells presents 
a recognition and engulfment signal for removal by phagocytosis competent cells even 
before the development of morphological changes usually associated with death (Schlegel & 
Williamson, 2001). 
4.4 Erythrocyte morphology 
The volume of red cells decreases with cell aging and substantial amount of hemoglobin is 
lost from circulating erythrocytes during total lifespan. This is probably due to loss of 
potassium and to loss of membrane via microvesiculation, resulting in cellular dehydration, 
membrane protein removal, and increased density.   
Vesicle formation appears to be accompanied by the breakdown of band 3 protein. It has 
been postulated that removal of senescent erythrocytes by macrophages is mediated by 
senescent cell-specific autoantigens originated on band 3, the anion exchanger and the 
major membrane protein of the erythrocyte (Kay, 2005). In accordance, Willekens et al. 
(2008) confirmed that vesiculation is not only associated with the removal of membrane-
bound hemoglobin, but is associated with generation of senescent cell antigen, a 
neoantigen that originates from band 3 after its breakdown in senescent red blood cells. 
Based on results from immunological analysis of vesicles and taken into consideration the 
existence of an efficient body mechanism to remove these vesicles, the authors concluded 
that vesiculation constitutes a mechanism for the removal of erythrocyte membrane 
patches containing removal molecules, thereby postponing the elimination of otherwise 
healthy erythrocytes. 
Allan and Thomas (1981) found the importance of a raised intracellular Ca2+ concentration 
in the microvesiculation process. Plasma membrane microvesiculation, induced in vitro by 
Ca2+, was found identical to that expressed by the very small subpopulation of in vivo 
senescent erythrocytes purified from peripheral blood of healthy donors (Bratosin et al., 
2001). Recent comparative proteomic analysis of erythrocytes and their vesicles provide new 
clues to the mechanisms involved in erythrocyte death (Bosman et al., 2010).  
The structure and molecular interaction of proteins within the complex assembly of the 
erythrocyte cytoskeleton explain the particular shape and shape transformations of these 
cells. Spectrin, band 3, actin, ankyrin, and other cytoskeletal proteins play an important role 
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for membrane integrity, typical discocyte form, and elasticity of red blood cells. Conversely, 
protein damage has been implicated in altered erythrocyte morphology. 
The shape of Ca2+-loaded erythrocytes changed from normal discocytes to echinocytes or 
spheroechinocytes with plasma membrane microvesiculation (Bratosin et al., 2001; Vota et 
al., 2010) (Figure 1). Morphological changes induced by A23187 in the presence of Ca2+ were 
associated with cell shrinkage, one of the characteristic features of apoptosis that 
distinguishes this active and regulated self-destruction process from the passive and chaotic 
event of necrosis induced by plasma membrane damage (Bratosin et al., 2001). 
On the other hand, stomatocytes were the main morphological cell transformation 
associated to in vitro (Vota et al., 2010) and in vivo (Richards et al., 2007; Antonelou et al., 
2011) oxidative stress (Figure 1).  
 
 
Fig. 1. Altered shapes of erythrocytes subjected to proeryptotic agents. The normal discoid 
biconcave shape (top) turned to spherocyte with microvesiculation due to increased 
intracellular calcium concentration (left bottom) or to stomatocyte induced by oxidative 
stress (right bottom). Results obtained in our laboratory.  
4.5 Protein modifications 
Erythrocyte membrane proteins are susceptible to covalent modification by the lipid 
peroxidation products generated by an oxygen radical attack. In vitro and in vivo assays in 
which erythrocyte metabolic alterations were associated to oxidant environments induced 
increased lipoperoxidation (Quintanar-Escorza et al., 2010; Calderón-Salinas et al., 2011).    
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The cytoplasmic domain of band 3 serves as a center of erythrocyte membrane organization 
and constitutes the major substrate of erythrocyte tyrosine kinases. Tyrosine 
phosphorylation of band 3 is induced by several stimuli, including malaria parasite 
invasion, cell shrinkage, normal cell aging, and oxidative stress (Harrison et al., 1991).  
Erythrocytes contain protein tyrosine kinase activity, with band 3 protein being the major 
substrate for the kinases (Brunati et al., 1996). Besides, phosphotyrosine phosphatase was 
found associated to band 3 protein. This phosphatase is normally highly active and 
prevents the accumulation of band 3 phosphotyrosine. However, in A23187-treated 
erythrocytes increased intracellular Ca2+ was found to promote band 3 tyrosine 
phosphorylation via dissociation of phosphotyrosine phosphatase from band 3 (Zipser et 
al., 2002).  
Tyrosine phosphorylation of band 3 markedly reduced its affinity for ankyrin, leading to 
release of band 3 from the spectrin/actin membrane skeleton, enhancement of the lateral 
mobility of band 3 in the bilayer, and progressive vesiculation. Because release of band 3 
from its ankyrin and adducin linkages to the cytoskeleton can facilitate changes in multiple 
membrane properties, the authors suggested that tyrosine phosphorylation of band 3 may 
produce changes in erythrocyte biology that allow the cell to respond to initial stress (Ferru 
et al., 2011). 
Another marker of red blood cell apoptosis is band 3 clustering, which generates a cell 
surface epitope identified by autologous IgG antibodies and may act as a signal for the 
removal of erythrocytes from circulation (Kay et al., 1989).  
The nitration of tyrosine residues in proteins occurs through the action of reactive oxygen 
and nitrogen species such as peroxynitrite, the product of the reaction between nitric oxide 
and superoxide anion. The nitrated peptides were able to activate lyn, an erythrocyte src 
tyrosine kinase. It suggested a mechanism of peroxynitrite-mediated signaling that may be 
correlated with upregulation of tyrosine phosphorylation (Mallozi et al., 2001).  
5. Processes that induce premature erythrocyte death 
Eryptosis can be triggered by different injuries such as energy depletion, osmotic shock or 
oxidative stress.  
5.1 Energy depletion  
As mentioned in Section 4.1, the reduced calcium-ATPase activity due to energy depletion 
leads to decreased calcium efflux and this in turn accelerates the transmembrane movement 
of potassium and chloride, resulting in cell dehydration. 
Energy stress also impairs the replenishment of glutathione and thus weakens the 
antioxidative defense of erythrocytes (Bilmen et al., 2001). Accordingly, this condition 
similarly activates cation channels affecting calcium flux (Duranton et al., 2002). On the other 
hand, phosphatidylserine and phosphatidylethanolamine are maintained in the cell inner 
leaflet by an ATP-dependent transporter known as flippase (Williamson & Schlegel, 2002). 
Membrane-bound Mg2+-ATPases seem to play a key role in the maintenance of the membrane 
lipid organization. This subfamily of ATPases has been reported to actively translocate 
aminophospholipids across membranes. Decreased ATP-dependent transport may be very 
well one of the consequences of phosphatidylserine exposure (Soupene & Kuypers, 2006). 
Besides, energy depletion involves activation of PKC and PKC-dependent phosphorylation of 
membrane proteins with subsequent stimulation of eryptosis (Föller et al., 2008). 
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5.2 Osmotic shock 
Osmotic shock is found among the well-known inducers of apoptotic cell death. The cellular 
mechanisms involved in the triggering of apoptosis following cell exposure to hypertonic 
extracellular fluid have been deeply studied in nucleated cells. Erythrocytes have similarly 
been shown to bind annexin following osmotic shock.  
Erythrocytes incubated in a hyperosmotic environment released prostaglandin E2 (PGE2), 
which in turn activated nonselective cation channels (Kaestner & Bernhardt, 2002; Lang PA et 
al., 2005), and increased the cytosolic Ca2+ concentration. Activation of the cell volume- and 
redox potential-sensitive cation channel and subsequent Ca2+ entry contributed to the 
development of erythrocyte cell membrane scrambling. Osmotic cell shrinkage was involved 
in the stimulation of sphingomyelinase which caused sphingomyelin degradation with 
subsequent release of ceramide in erythrocytes (Lang et al., 2004). Ceramide then activated 
scramblase leading to breakdown of phosphatidylserine asymmetry of the cell membrane. The 
ability of ceramide to induce this kind of erythrocyte death was somewhat surprising, as 
erythrocytes lack mitochondria, crucial elements in the ceramide-triggered signaling cascade 
in nucleated cells (Lang et al., 2004). Thus, at least in erythrocytes, ceramide must trigger 
annexin binding through a pathway distinct from that described in nucleated cells.  
5.3 Oxidative stress 
Increasing intracellular oxidants by altering ambient oxygen concentrations or lowering 
antioxidant levels accelerates the onset of erythrocyte senescence whereas lowering ambient 
oxygen or increasing reactive oxygen species (ROS) scavenging appears to delay senescence. 
In general, conditions that induce senescence often appear to be accompanied by a rise in 
intracellular ROS levels. Polyunsaturated fatty acids within the membrane, an oxygen rich 
environment, and iron-rich hemoglobin make red cells susceptible to peroxidative damage.  
The product of membrane lipid peroxidation can affect the anion transport function and 
activity of enzymes of the glycolytic pathway associated to band 3 (Dumaswala et al., 1999). 
By virtue of its potent oxidant and nitrating ability, peroxynitrite has been proposed as an 
important mediator of inflammation-induced tissue injury and dysfunction, and it is 
considered the most efficient nitrating species of biological relevance (Szabó et al., 2007). The 
red blood cells are, in fact, the major scavengers of peroxynitrite in blood and it has been 
calculated that at 45% hematocrit about 40–45% of peroxynitrite crosses the cell membrane 
and quickly reacts with hemoglobin, while the remainder reacts extracellularly with carbon 
dioxide (Romero & Radi, 2005). In an in vitro experimental system mimicking the oxidative 
imbalance detectable in vivo, peroxynitrite acted both extra- and intracellularly as a function 
of cell density and carbon dioxide concentration, inducing the appearance of distinct cellular 
biomarkers as well as modulation of metabolism (Pietraforte et al., 2007). Intracellular 
oxidations, due mostly to direct reactions of peroxynitrite with glutathione and hemoglobin 
(methemoglobin), lead to decreased ATP and the appearance of apoptotic signs, such as 
clustering of band 3, externalization of phosphatidylserine, and activation of caspases. 
Surface/membrane oxidations were principally due to indirect radical reactions causing 
oxidation of surface thiols, formation of membrane-associated 3-nitrotyrosine, and 
downregulation of glycophorins A, the latter being considered a senescence biomarker 
(Matarrese et al., 2005; Pietraforte et al., 2007; Metere et al., 2009).  
6. In vivo erythrocyte death and possible prevention 
Oxidative stress is a term used to describe the body’s prolonged exposure to oxidative 
factors that cause more free radicals than the body can neutralize. Under this condition, free 
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radical formation may play a role in the pathophysiology of several diseases. There is 
evidence that erythrocytes undergo oxidative changes in conditions where free radical 
formation is known to be high such as rheumatoid arthritis (Richards et al., 2007), diabetes 
(Manuel y Keenoy et al., 2001; Calderón-Salinas et al., 2011), and hemodialysis treatment 
(Zachee et al., 1988). Oxidative damage was also considered the cause of decreased 
deformability and altered rheology of erythrocytes found in individuals with chronic fatigue 
syndrome, a condition that may be triggered by certain infectious diseases, multiple nutrient 
deficiencies, food intolerance, or extreme physical or mental stress (Richards et al., 2007). 
Erythrocyte alterations would have the physiological effect of reducing oxygen delivery to 
the tissues. In several models, 2,3-diphosphoglycerate (2,3-DPG) levels were increased and 
this effect may be explained as a compensation since 2,3-DPG have the effect of decreasing 
oxygen affinity. Therefore, this would allow more oxygen to be delivered to the tissues. 
Any erythrocyte disorder facilitating erythrocyte shrinkage, could, to the extent as it leads to 
activation of the cell volume regulatory cation channels, trigger premature apoptosis and 
thus accelerate erythrocyte death. Red blood cells from patients with sepsis (Kempe et al., 
2007), sickle cell disease (Wood et al., 1996), thalassemia (Kuypers et al., 1998), glucose-6-
phosphate dehydrogenase deficiency (Lang et al., 2002), and phosphate depletion (Birka et 
al., 2004) are more sensitive to apoptotic stimuli, a property correlating with the shortened 
erythrocyte lifespan in these disorders. Membrane lipid disorders play an important role in 
the pathology of hemoglobinopathies, leading to premature removal (anemia) and 
imbalance in hemostasis (e.g. lipid breakdown products of phosphatidylserine-exposed cells 
result in vascular dysfunction) (Neidlinger et al., 2006).  
Altered phosphorylation of erythrocyte cytoskeletal proteins and increased ROS production 
result in disruption of cytoskeleton stability in healthy and sickle cell erythrocytes (George 
et al., 2010). 
Significant modifications in red blood cell structure and membrane proteome in end stage 
renal disease patients were observed in the context of increased ROS accumulation. The 
intrinsic oxidative stimuli related to the uremic state were closely associated with membrane 
cytoskeleton instability, loss of surface area through vesiculation, and transformation of 
normal discocytes. The observed alterations might contribute to premature erythrocyte 
death and to the progression of anemia (Antonelou et al., 2011). 
Under normal conditions, red blood cells are continuously exposed to ROS from both internal 
and external sources. In healthy erythrocytes, significant oxidative damage is prevented by a 
very efficient antioxidant system, consisting of enzymatic and nonenzymatic pathways. 
Enzymes for preventing oxidative denaturation in erythrocytes include superoxide dismutase, 
catalase, glutathione peroxidase and glutathione reductase which sustain glutathione 
regeneration, and NADH-methemoglobin reductase. In addition to primary antioxidant 
defense systems that prevent the generation of free radicals or radical chain reactions, 
secondary systems have been proposed. These include proteases that preferentially degrade 
proteins damaged by oxidation. Endogenous non-enzymatic antioxidants also provide defense 
against oxidative damage: they are lipophylic (vitamin E, carotenoids, melatonin) and water 
soluble compounds  (vitamin C, gluthatione, ceruloplasmin, uric acid) (Burak Çimen, 2008). 
Free radicals are produced as intermediate products of normal metabolic functions. Thus, 
antioxidants function as modulators of cellular homeostasis including detoxification of 
radicals and metals as well as potent free radical scavengers. 
Erythropoietin, the hormone that is the principal regulator of red blood cell production, 
prevents apoptosis of erythroid progenitors, supporting their survival. It is well known that 
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the target cells for erythropoietin are the progenitors of erythrocytes found in the 
hematopoietic organs. However, early works have shown prolonged red blood cell survival 
during treatment with recombinant human erythropoietin (Schwartz et al., 1992; 
Polenakovic & Sikole, 1996), suggesting a contribution to the maintenance of corrected 
hematocrit values. Later, other works were performed to elucidate mechanisms of action of 
erythropoietin upon mature erythrocytes. Myssina et al. (2003) reported that erythropoietin 
inhibited cell death through a direct effect via erythropoietin receptor on mature 
erythrocytes. Unlike the general knowledge of the absence of erythropoietin receptors in 
reticulocytes, the authors detected the expression of about six erythropoietin binding sites 
per mature red blood cell. In this work, they postulated that erythropoietin bound to 
erythrocytes inhibited the volume-sensitive cation channel responsible for calcium entry, 
and thus blocked phosphatidylserine translocation. More investigation is needed to 
elucidate the erythropoietin effects upon erythrocytes, since it is well known that 
erythropoietin induces increased intracellular Ca2+ concentration in human erythroid 
progenitors when they are activated via binding of the hormone with its specific receptor.   
On the other hand, a direct effect of erythropoietin on mature erythrocytes might be 
possible, since erythropoietin similar to other proteins would protect red cell membranes 
from lipid peroxidation by scavenging hydroxyl radicals generated by oxidative stress. 
Chattopadhyay et al. (2000) reported that the oxidative damage brought about by copper (II) 
ascorbate upon red blood cells was due to generation of hydroxyl radical and that 
erythropoietin was able to protect the membrane from oxidative damage.  
In a preliminary study, mature erythrocytes from patients with chronic renal insufficiency 
exhibited higher annexin binding when compared with red blood cells from healthy 
individuals. Moreover, the number of cells expressing phosphatidylserine externalization 
decreased after dialysis only when patients received erythropoietin immediately before 
dialysis (Myssina et al., 2003). Irrespective the erythropoietin mechanism it seems that the 
hormone does not only inhibit apoptosis of erythroid progenitor cells, but blunts the 
suicidal death of mature erythrocytes. This protective antieryptotic mechanism may 
ameliorate erythrocyte death in vivo, resulting in increased lifespan of circulating cells.  
7. Conclusion 
The human red blood cell, by lacking nucleus or any other subcellular organelle, represents 
the final differentiation stage of the erythroid series. After a limited period in circulation, 
aged cells become sequestered and removed by macrophages from the reticuloendothelial 
system. This fate implies that erythrocyte life and death should be well regulated.  
Senescence of red blood cells occurs along their lifespan in the vascular system. During 
aging, erythrocytes display molecules that lead to recognition and removal of old damaged 
cells by the immune system. Current evidence indicates that neoantigens on altered band 3 
and phosphatidylserine exposed at the outside of erythrocytes are the main signals for cell 
removal and phagocytosis. Vesicles, generated as an integral part of the aging process 
probably to remove damaged membrane patches, disappear rapidly from circulation. The 
formation of vesicles as well as changes in electrolyte movements lead to decreased cell 
volume. Disruption of cell metabolism, hemoglobin denaturalization, changes in 
cytoskeletal protein interaction, protein phosphorylation/dephosphorylation disbalance, 
and membrane protein modifications are among the factors responsible for the appearance 
of morphological alterations.  
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Considering that senescence represents the time-dependent induction of erythrocyte self-
destruction process, premature cell death due to proeryptotic factors could greatly 
contribute to the development of anemia.  
Energy depletion, oxidative stress, and osmotic shock are the most common events that can 
produce erythrocyte damage, leading to premature eryptosis (Fig. 2). The common feature is 
the increased intracellular calcium concentration due to either calcium channel activation or 
depressed calcium pump. Calcium accumulation in turn activates the potassium channel 
favoring this cation efflux, followed by chloride and water exit, which in conjunction 
generate cell shrinkage. Calpain, activated by calcium, affects cytoskeletal proteins inducing 
membrane destabilization and blebbling, and is involved in scramblase activation, thus 
facilitating phosphatydilserine translocation.  
 
 
Fig. 2. Mechanisms involved in programmed erythrocyte death. B3: band 3; ROS: reactive 
oxygen species; Hb: hemoglobin; MetHb: methemoglobin; GPA: glycophorin A; PTKs: 
phosphotyrosine kinases; PTPs: phosphotyrosine phosphateses; PS: phosphatidylserine. 
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Additional increase in intracellular oxidants by altering ambient oxygen concentrations or 
lowering antioxidant levels also accelerates the onset of senescence. Concurrent effects 
mediated by oxidized hemoglobin and by protein phosphorylation due to disbalance in the 
kinase/phosphatase ratio are directed towards erythrocyte damage, and consequently to 
eryptosis.  
It is evident that elucidation of mechanisms that regulate eryptosis is a complex issue 
because of technical problems in obtaining purified cell fractions of a well-defined cell age 
or in the correct manipulation of erythrocytes in vitro, and especially due to the low 
probability to test hypothesis of programmed erythrocyte death in vivo. However, to get an 
insight into this mechanism is essential for understanding the pathological circumstances 
surrounding anemia associated to many different diseases.  
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